Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San Raffaele, shared on X:
“What is the performance of neoadjuvant pembro in PURE01 vs periop EVP KEYNOTE905 in pts with MIBC?
Are this data replicable in a multicentric setting? Waiting for a post-hoc analysis of KN905 to be presented at ESMO26.”
Title: Indirect comparison of reconstructed individual patient data from KEYNOTE-905/EV-303 and PURE-01: complementary analyses for interpreting event-free survival in muscle-invasive bladder cancer
Authors: Brigida Anna Maiorano, Andrea Necchi
You can also read:
